NEW YORK, Nov. 20 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb (NYSE:
BMY) today announced the results of the tender offer for its 5.75% notes
due October 1, 2011, which closed at 5:00 p.m. New York Time, on Friday,
November 17, 2006.
In aggregate $1,817,892,000 principal amount of notes was tendered in
the offer. Bristol-Myers Squibb will repurchase all notes validly tendered
for settlement November 27, 2006. The offer was contingent upon meeting
certain conditions described in the Offer to Purchase dated November 9,
2006, including the Financing Condition. All of the conditions have been
met.
As announced on November 16, 2006, Bristol-Myers Squibb will pay
$1,037.16 plus $8.94 of accrued interest per $1,000 principal amount
tendered.
CUSIP Title of Security Principal Amount Principal Amount
Outstanding Tendered
110122AG3 5.75% Notes
due October 11, 2011 $2,500,000,000 $1,817,892,000
Bristol-Myers Squibb Company is a global pharmaceutical and related
health care products company whose mission is to extend and enhance human
life.
SOURCE Bristol-Myers Squibb
 back to top
Related links:
http://www.bms.com
CONTACT:
Media, Tony Plohoros, +1-212-546-4379,
tony.plohoros@bms.com, or Jeff Macdonald, +1-212-546-4824,
jeffrey.macdonald@bms.com, or Investors, John Elicker,
+1-212-546-3775, john.elicker@bms.com, or Blaine Davis,
+1-212-546-4631, blaine.davis@bms.com, all for Bristol-Myers
Squibb
|
